| Young Sung Hong, MD | |
|
501 Medical Dr, Hampton, VA 23666-6080 | |
| (757) 826-3434 | |
| (757) 826-9028 |
| Full Name | Young Sung Hong |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 501 Medical Dr, Hampton, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235121369 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 0101021809 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Young Sung Hong, MD 501 Medical Dr, Hampton, VA 23666-6080 Ph: () - | Young Sung Hong, MD 501 Medical Dr, Hampton, VA 23666-6080 Ph: (757) 826-3434 |
News Archive
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
Two Johns Hopkins scientists have figured out a simple way to make millions upon millions of drug-like peptides quickly and efficiently, overcoming a major hurdle to creating and screening huge "libraries" of these super-short proteins for use in drug development.
Shire plc has announced that it licensed the North America (U.S. and Canada) rights for the investigational HIV compound, SPD754 (also known as apricitabine), to the Australian biotechnology company Avexa Limited in return for an up-front payment of US$10 million, development and sales related milestones and royalties.
Medtronic, Inc., and ATS Medical, Inc., today announced that the companies have signed a definitive agreement under which Medtronic will acquire ATS Medical by paying $4.00 per share in cash for each share of ATS Medical stock.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
Dr. Sridhar Madhunapantula, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Hayden Allen Ross-clunis Iii, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 Fax: 757-728-3126 | |
Irene Paula San Roman, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Dr. Naga S Chigurupati, M.D. Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 2207 Executive Dr Ste B, Hampton, VA 23666 Phone: 757-224-8919 | |
Myung Woong Kim, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 501 Medical Dr, Hampton, VA 23666 Phone: 757-826-7785 Fax: 757-826-9028 | |
Stephen E Lapinel, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 4000 Coliseum Dr, Suite 350, Hampton, VA 23666 Phone: 757-827-2127 Fax: 757-827-2255 | |
Dr. William Edward Brown Iii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6 Manhattan Sq Ste 100, Hampton, VA 23666 Phone: 757-826-2102 Fax: 757-825-9482 |